Invesco Ltd. Innoviva, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 1,562,632 shares of INVA stock, worth $31.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,562,632

Previous 1,263,437 23.68%

Holding current value

$31.1 Million

Previous $19.3 Million 33.1%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $4.31 Million - $4.91 Million	299,195 Added 23.68%	1,562,632 $25.6 Million
Q1 2024 May 14, 2024	BUY	$14.56 - $16.78 $1.58 Million - $1.82 Million	108,465 Added 9.39%	1,263,437 $19.3 Million
Q4 2023 Feb 12, 2024	BUY	$12.32 - $16.27 $6.07 Million - $8.02 Million	492,994 Added 74.47%	1,154,972 $18.5 Million
Q3 2023 Nov 13, 2023	BUY	$12.37 - $13.89 $2.91 Million - $3.27 Million	235,330 Added 55.16%	661,978 $8.6 Million
Q2 2023 Aug 11, 2023	SELL	$11.39 - $13.72 $745,464 - $897,960	-65,449 Reduced 13.3%	426,648 $5.43 Million
Q1 2023 May 12, 2023	SELL	$10.73 - $13.6 $752,848 - $954,216	-70,163 Reduced 12.48%	492,097 $5.54 Million
Q4 2022 Feb 13, 2023	BUY	$11.8 - $13.78 $276,249 - $322,603	23,411 Added 4.34%	562,260 $7.45 Million
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $7.87 Million - $10.3 Million	-678,037 Reduced 55.72%	538,849 $6.26 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $1.31 Million - $1.82 Million	-91,441 Reduced 6.99%	1,216,886 $18 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $10.3 Million - $13.6 Million	669,799 Added 104.9%	1,308,327 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $2.82 Million - $3.32 Million	177,540 Added 38.51%	638,528 $11 Million
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $23.4 Million - $30.9 Million	-1,790,928 Reduced 79.53%	460,988 $7.7 Million
Q2 2021 Aug 17, 2021	SELL	$11.45 - $13.96 $2.48 Million - $3.03 Million	-216,963 Reduced 8.79%	2,251,916 $30.2 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $571,658 - $665,211	-51,687 Reduced 2.05%	2,468,879 $29.5 Million
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $1.6 Million - $2.14 Million	171,451 Added 7.3%	2,520,566 $31.2 Million
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $10 Million - $14.1 Million	972,506 Added 70.65%	2,349,115 $24.5 Million
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $1.41 Million - $1.88 Million	-123,032 Reduced 8.2%	1,376,609 $19.2 Million
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $5.14 Million - $9.66 Million	-634,259 Reduced 29.72%	1,499,641 $17.6 Million
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $4.09 Million - $5.73 Million	398,254 Added 22.95%	2,133,900 $30.2 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $755,589 - $1.09 Million	-75,183 Reduced 4.15%	1,735,646 $18.3 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $4.06 Million - $4.63 Million	-309,648 Reduced 14.6%	1,810,829 $26.4 Million
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $813,925 - $1.19 Million	-59,454 Reduced 2.73%	2,120,477 $29.8 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $30.4 Million - $39.8 Million	2,179,931 New	2,179,931 $38 Million

Others Institutions Holding INVA

# of Institutions

221

Shares Held

78.9M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.39B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account